Currently, AHA/ACC practice guidelines for heart failure recommend angiotensin converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers for asymptomatic LV dysfunction (stage B heart failure). This evidence concerns the gene ACE and heart failure.